정맥혈전 색전증 치료 시장 규모, 점유율, 성장 분석 : 제품별, 적응 질환별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Venous Thromboembolism Treatment Market Size, Share, and Growth Analysis, By Product, By Disease Indication, By End User, By Region - Industry Forecast 2025-2032
상품코드:1677842
리서치사:SkyQuest
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 정맥혈전 색전증 치료 시장 규모는 2023년에 22억 달러로 평가되며, 2024년 23억 1,000만 달러에서 2032년에는 34억 1,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 5.0%로 성장할 전망입니다.
정맥혈전색전증(VTE) 치료 시장은 폐색전증 및 심부정맥혈전증과 같은 심각한 합병증을 유발할 수 있는 정맥내 혈전 형성으로 특징지어지는 심각한 세계 건강 문제를 해결하는 데 중요한 역할을 하고 있습니다. 이 시장의 주요 촉진요인으로는 좌식 생활습관, 고령화, 수술과 관련된 VTE의 유병률 증가, 효과적인 치료법에 대한 수요 증가 등이 있습니다. 항응고 요법, 특히 직접 경구용 항응고제(DOAC)와 주사제의 발전은 출혈 위험을 최소화하면서 치료 결과를 개선하고 있습니다. 위험 요인에 대한 인식이 높아지고 조기 진단의 중요성이 높아지면서 시장 성장을 더욱 촉진하고 있습니다. 맞춤 치료 접근법의 필요성과 환자의 순응도라는 과제에도 불구하고 VTE 치료 시장은 생명을 구하는 중재를 제공하는 데 있으며, 필수적인 역할을 하고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
정맥혈전 색전증 치료 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
비부문형 공기압축 펌프
구배 없는 부문형 공기압축 펌프
교정 구배가 있는 부문형 공기압축 펌프
상부 공기압축 슬리브
하부 공기압축 슬리브
영구 하대정맥 필터
회수 가능한 하대정맥 필터
색전제거 풍선 카테터
경피혈전 제거 기기
카테터 유도 혈전용해(CDT) 기기
정맥혈전 색전증 치료 시장 규모 : 적응 질환별 & CAGR(2025-2032)
시장 개요
심부정맥혈전증
폐색전증
정맥혈전 색전증 치료 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
병원
카테터 검사실
외래 수술 센터
정맥혈전 색전증 치료 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Johnson & Johnson(USA)
Pfizer Inc.(USA)
Bayer AG(Germany)
Bristol Myers Squibb(USA)
Daiichi Sankyo Company, Limited(Japan)
Boehringer Ingelheim(Germany)
Novartis AG(Switzerland)
Aspen Pharmacare Holdings Limited(South Africa)
Abbott Laboratories(USA)
Medtronic plc(Ireland)
Boston Scientific Corporation(USA)
Cardinal Health, Inc.(USA)
Terumo Corporation(Japan)
Cook Medical(USA)
Getinge AB(Sweden)
Teleflex Incorporated(USA)
Smith+Nephew(UK)
Baxter International Inc.(USA)
Instrumentation Laboratory(USA)
결론과 제안
KSA
영문 목차
영문목차
Global Venous Thromboembolism Treatment Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.31 billion in 2024 to USD 3.41 billion by 2032, growing at a CAGR of 5.0% during the forecast period (2025-2032).
The venous thromboembolism (VTE) treatment market plays a crucial role in addressing a significant global health issue marked by blood clot formation in veins, which can lead to serious complications such as pulmonary embolism and deep vein thrombosis. Key drivers of this market include the rising prevalence of VTE linked to sedentary lifestyles, aging populations, and surgical procedures, creating a demand for effective treatments. Advancements in anticoagulant therapies, particularly direct oral anticoagulants (DOACs) and injectable options, have improved treatment outcomes while minimizing bleeding risks. Increased awareness of risk factors and the importance of early diagnosis further bolster market growth. Despite challenges like the need for personalized treatment approaches and patient compliance, the VTE treatment market remains vital in delivering life-saving interventions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Venous Thromboembolism Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Venous Thromboembolism Treatment Market Segments Analysis
Global Venous Thromboembolism Treatment Market is segmented by Product, Disease Indication, End User and region. Based on Product, the market is segmented into Non-Segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps without Gradient, Segmented Pneumatic Compression Pumps with Calibrated Gradient, Upper Pneumatic Compression Sleeves, Lower Pneumatic Compression Sleeves, Permanent Inferior Vena Cava Filters, Retrievable Inferior Vena Cava Filters, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices and Catheter-Directed Thrombolysis (CDT) Devices. Based on Disease Indication, the market is segmented into Deep Venous Thrombosis and Pulmonary Embolism. Based on End User, the market is segmented into Hospitals, Catheterisation Laboratories and Ambulatory Surgical Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Venous Thromboembolism Treatment Market
The global market for Venous Thromboembolism (VTE) treatment is significantly influenced by the rising prevalence of VTE cases, which is attributed to several factors including aging populations, sedentary lifestyles, and post-surgical complications. As VTE presents serious health challenges, there is an increasing emphasis on its timely detection and effective treatment. This heightened awareness and focus on managing VTE are propelling the growth of the market, as healthcare providers and patients alike prioritize strategies to mitigate the risks associated with this condition. Consequently, investment in innovative treatment options and preventive measures is becoming increasingly vital in addressing this public health concern.
Restraints in the Global Venous Thromboembolism Treatment Market
The Global Venous Thromboembolism (VTE) Treatment market faces a significant restraint due to the complexity and length of treatment regimens required to effectively manage VTE. These intricate protocols can lead to challenges in patient adherence, as the extended duration and demanding nature of the treatments may overwhelm individuals. Consequently, non-compliance can adversely affect the overall outcomes of the treatment, hindering progress and recovery. This issue emphasizes the need for strategies to simplify treatment plans and enhance patient engagement in order to improve therapeutic results and ensure a more effective management of VTE across diverse populations.
Market Trends of the Global Venous Thromboembolism Treatment Market
The Global Venous Thromboembolism (VTE) Treatment market is witnessing a significant trend towards the adoption of Direct Oral Anticoagulants (DOACs), which have gained popularity for their superior efficacy and convenience compared to traditional warfarin. Medications such as apixaban, rivaroxaban, and edoxaban are favored due to their reduced monitoring requirements and ease of use, making them increasingly attractive to both healthcare providers and patients. This paradigm shift is expected to drive market growth, as healthcare systems increasingly recognize the benefits of DOACs, ultimately improving patient outcomes and adherence in VTE management.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Venous Thromboembolism Treatment Market Size by Product & CAGR (2025-2032)
Market Overview
Non-Segmented Pneumatic Compression Pumps
Segmented Pneumatic Compression Pumps without Gradient
Segmented Pneumatic Compression Pumps with Calibrated Gradient
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Retrievable Inferior Vena Cava Filters
Embolectomy Balloon Catheters
Percutaneous Thrombectomy Devices
Catheter-Directed Thrombolysis (CDT) Devices
Global Venous Thromboembolism Treatment Market Size by Disease Indication & CAGR (2025-2032)
Market Overview
Deep Venous Thrombosis
Pulmonary Embolism
Global Venous Thromboembolism Treatment Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centres
Global Venous Thromboembolism Treatment Market Size & CAGR (2025-2032)
North America (Product, Disease Indication, End User)
US
Canada
Europe (Product, Disease Indication, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Disease Indication, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Disease Indication, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Disease Indication, End User)
